Online Trial Tracker - Larvol Sigma

AK127 / Akesobio

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

AK127 / Akesobio

NCT05951608: A Phase Ib/II Clinical Study of AK127 in Combination With AK112 in Patients With Advanced Solid Tumors

Not yet recruiting

1/2

216

AK127 in combination with AK112

Akeso

Advanced Solid Tumors

07/25

07/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites